Navigation Links
Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill
Date:2/6/2009

KENSINGTON, Md., Feb. 6 /PRNewswire-USNewswire/ -- "Psoriasis Cure Now," a nonprofit patient advocacy organization, has launched a micro-Web site, www.StimulateResearch.com, to help everyday Americans interested in medical research be heard in the stimulus debate that has been dominated by powerful lobbyists and special interests. The Web site allows people to write their lawmakers urging them to make biomedical research a meaningful part of any stimulus bill that emerges in the coming days. The nearly $1 trillion bill sweeping through Congress could crowd out medical research funding at the National Institutes of Health (NIH) for years to come.

"This is the fastest I have seen Washington allocate $1 trillion in my quarter century following politics," said Michael Paranzino, president of Psoriasis Cure Now. "It seems to have caught the patient advocacy community flat-footed. But medical research is every bit as 'shovel ready' and 'stimulative' as Austin's proposed Frisbee golf course or the projects Chicago won't even disclose. Dollars wasted now will not cure cancer, arthritis or psoriasis tomorrow. Our Web site lets Americans concerned about curing disease make sure medical research is not neglected as the final stimulus package is hammered out in the coming week."

The House-passed stimulus bill includes a few billion for NIH (much of it to build new buildings), and the current Senate version includes $10 billion for NIH over two years. But a bipartisan group of Senators is looking to cut more than $100 billion from the current version, and the House-Senate Conference Committee is expected to make significant additional revisions, meaning the fate of medical research is highly uncertain. For the last five years, NIH funding has been stagnant, with thousands of well-designed and 'shovel ready' grant requests by scientists from all 50 states being held up by
'/>"/>

SOURCE Psoriasis Cure Now
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
2. Gene Insights May Improve Psoriasis Care
3. Scientists unmask genetic markers associated with psoriasis
4. An Oral Agent for the Treatment of Moderate to Severe Psoriasis Would Earn a Higher Patient Share in the United States than in Europe
5. Obesity-Related Hormone Tied to Psoriasis
6. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
7. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
8. Indigo Ointment Benefits Psoriasis Patients
9. National Psoriasis Foundation Seeks 10,000 Americans to Support Psoriasis Research for World Psoriasis Day
10. National Psoriasis Foundation Releases 2008 Study Results
11. After Fits and Starts, New Hope for Psoriasis Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... Health Network (MHN) urges military veterans to l...nked to exposure to chemicals, atomic agents and s... is one of those cancers that is two times more pr...ked or currently smoke cigarettes. , ... -- Men’s Health Network (MHN) kicked-off th...
(Date:11/8/2009)...USNewswire/ -- USAction this evening hailed passag...hich will make health care more affordable for con...ncrease access to health care for millions of Amer...elt, FDR and Harry Truman would be proud," said US...e ranks among our country,s proudest achievements....
(Date:11/8/2009)...es With Working Families vs. Insurance Companies ...re/ -- On the heels of an historic late night vote...ced health care reform bill, the Pennsylvania AFL-...epresentatives voted on HR 3962, the Affordable He... which passed Saturday evening by a vote of 220 to...
(Date:11/7/2009)...Newswire/ -- The American Medical Association (AMA...itizenship and Community Service to Manus C. Kraff...ward recognizes physicians who have gone above and... outstanding public service contribution to their ...y during the opening session of the 2009 Interim M...
(Date:11/7/2009)...USNewswire/ -- With the final House vote on health...ding the entire bill hostage to further their anti...go far beyond the status quo restrictions on abort...ill. In an outrageous amendment, which is expecte...ice Democrats are demanding explicit and unequivoc...
Breaking Medicine News(10 mins):Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
..., researchers say , , MONDAY, March 16 (H... blood flow after a heart attack, but the benefit ..., a new Swiss study finds. , "The main goal of our...iac Rehabilitation Center at the Clinique Valmont-...
...y plays a significant role in the production of al...fter a myocardial infarction, according to a study...ers. , The findings, which will be published on... Beta-arrestin-1 binds to angiotensin II receptors...
...Hilda L. Solis today announced the withdrawal of a...r occupational exposure to food flavorings contain...the Labor Department,s Occupational Safety and Hea...sease associated with such an exposure. , , "I a...
...ly unemployed, can attend a local seminar or talk ...h 16 As the nation marks National Cover the Unins...g resources to help Pennsylvanians without health ...ve risen to one million Pennsylvanians in 2008, up...
...e/Preferred Care and Excellus BlueCross BlueShield...ho treat adults to improve the way patients receiv...health insurers are inviting up to 20 internal med...in or reduce health care costs and to improve phys...
...e the undignified hospital Johnny , , NORTHAMPTON... dedicated to helping homeless veterans of the Uni... integrity, dignity and hope, is looking to restor...l for assisting homeless veterans, hopes to partne...
Other Medicine News:Health News:Any Exercise Good After a Heart Attack 2Health News:Any Exercise Good After a Heart Attack 3Health News:New target for heart failure therapy identified 2Health News:U.S. Secretary of Labor Hilda L. Solis takes action to prevent workers' exposure to food flavorings chemical 2Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 2Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 3Health News:Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit 2Health News:Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit 3Health News:Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit 4Health News:Non-Profit Seeks Partners for Major Cover-Up 2
(Date:11/6/2009)..., RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNew...any advancing orally-available antiviral therapeut...d updates on the development of the company,s lead...rganization (WHO) and the Global Health Security I...viral agent being developed for the treatment of s...
(Date:11/6/2009)..., DETROIT, Nov. 6 C...: CPD ) has launched ketorolac tromethamine ophth...om the US Food and Drug Administration (FDA) for S...) for generic Acular® opthalmic solution on t...ength of ketorolac is therapeutically equivalent t...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Althea T...nt and manufacturing services for biopharmaceutica...rmulation Development to the company,s platform of...ointed Dr. James Matsuura, Director of Formulation...am of formulation and analytical scientists, along...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 1iTech Medical Provides Update on MPR Clinical Development Plan 58632 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 3iTech Medical Provides Update on MPR Clinical Development Plan 58632 4Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 1Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 2Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 3Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 4Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 1Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 2
...xin Demonstrates Promising Clinical Activity in Pa...t Cancers -, SOUTH SAN FRANCISCO, Calif., Nov. 6 ...esented data from three clinical,trials of the com...S-595),at the Chemotherapy Foundation Symposium he...esented from Phase 1 and Phase 1b/2 studies in pat...
...Study of Its Kind, PASADENA, Calif., Nov. 4 Proa... average of 37.2 percent -- and as much as 50,perc...onducted by Kaiser,Permanente Southern California....he Journal of Bone & Joint Surgery, a peer-reviewe...ve-year study tracked more than,625,000 male and f...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 2Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 3Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 4Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 5Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 2Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 3Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 4
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: